상단여백
기사 (전체 928건)
미 CDC 국장 "마스크 의무화 해제는 시기상조"
"치매환자 코로나에 걸릴 확률 두 배 높아"-美연구진
화이자 백신, 영국서 발견된 변종 코로나에 '효과'
"올해 바이러스 변이 더욱 많아질 것"-남아공 전문가
전 세계 코로나 백신 접종자 1000만명 넘어서
라인
전세계 40여개국 '변이 바이러스 출현' 영국 여행제한
알보젠코리아 머시론, '공식 웹사이트 리뉴얼' 오픈…직관적 메뉴와 세로형 단일 페이지 구성으로 정보 접근성 강화
대웅제약 '올로스타' 우수한 효과·독보적 기술력 주목…특허 플랫폼 기술 '방출 속도 조절 이층정' 제형 접목으로 체내 약물 흡수 최적화
Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic Syndromes(HR-MDS)
Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders
라인
Takeda Provides Updates on its Hemophilia Studies at WFH 2020, Reinforcing its Commitment to Putting Patients First and Supporting Personalized Care for People with Bleeding Disorders
Takeda Presents Positive Data from Clinical Trial Evaluating Oral NINLARO(ixazomib) in Multiple Myeloma as a First-Line Maintenance Therapy
New Data from the Phase 3 HELP Study Open-Label Extension Evaluate the Long-Term Safety and Efficacy of TAKHZYRO? (lanadelumab) in Reducing Hereditary Angioedema Attacks
Takeda to Present Data from the ICLUSIG? (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML
GSK 한국법인, Country Medical Director에 김똘미님 선임
라인
Takeda Announces U.S. FDA Breakthrough Therapy Designation for Mobocertinib(TAK-788) for the Treatment of NSCLC Patients with EGFR Exon 20 Insertion Mutations
European Commission Approves Subcutaneous Formulation of Entyvio? (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease
European Commission Approves Takeda’s ALUNBRIG? (brigatinib) as a First-Line Treatment for ALK+ NSCLC
ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV
U.S. FDA grants Fast Track designation to empagliflozin for the treatment of chronic kidney disease
Back to Top